Trial Profile
A Single-dose, 2-part, Open-label, Randomised, Pharmacoscintigraphic Investigation Into the Absorption of Nevirapine When Released Into Different Parts of the Gastro-intestinal Tract
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Jul 2014
Price :
$35
*
At a glance
- Drugs Nevirapine (Primary) ; Nevirapine
- Indications HIV infections; HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 21 Jul 2014 New trial record